CVR Medical Corp V.CVM.H

Alternate Symbol(s): CRRVF

Healthcare Biotechnology

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.

TSXV:CVM.H - Post by User

CVR Medical Corp > New Proposal

<< Previous

Bullboard Posts

Next >>

Comment by Looneytuneson Apr 22, 2021 2:11pm

174 Views

Post# 33046211

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Proposal

My preference would be for the alternative plan proposed by the restructuring group because that would more fairly represent the interest of all shareholders however fwiw if we MUST have this structure my preference would be for the warrants to be staggered at prices from $1 to $5 with annual expiry dates starting year 3 running to year 7, and for a 5% commission not based on manufacturers recommended price but on the net profit from the CSS.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal